Cell-free DNA testing

future applications in gastroenterology and hepatology

Inuk Zandvakili, Konstantinos N Lazaridis

Research output: Contribution to journalReview article

Abstract

The application of next-generation sequencing in clinical practice is increasing as accuracy and interpretation have improved and the cost continues to decline rapidly. Cell-free DNA is a unique source for next-generation sequencing that could change routine clinical practice in gastroenterology and hepatology. Testing of cell-free DNA in blood and fecal samples is an easy, rapid, and noninvasive method to assess for premalignant, malignant, metabolic, infectious, inflammatory, and autoimmune gastrointestinal and liver diseases. In this review, we describe cell-free DNA technologies, current applications of cell-free DNA testing, and proposed cell-free DNA targets for gastrointestinal and hepatic diseases, with a specific focus on malignancy. In addition, we provide commentary on how cell-free DNA can be integrated into clinical practice and help guide diagnosis, prognosis, disease management, and therapeutic response.

Original languageEnglish (US)
JournalTherapeutic Advances in Gastroenterology
Volume12
DOIs
StatePublished - Apr 1 2019

Fingerprint

Gastroenterology
DNA
Gastrointestinal Diseases
Disease Management
Autoimmune Diseases
Liver Diseases
Technology
Costs and Cost Analysis
Liver
Neoplasms

Keywords

  • cell-free DNA
  • gastroenterology and hepatology
  • individualized medicine

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Cell-free DNA testing : future applications in gastroenterology and hepatology. / Zandvakili, Inuk; Lazaridis, Konstantinos N.

In: Therapeutic Advances in Gastroenterology, Vol. 12, 01.04.2019.

Research output: Contribution to journalReview article

@article{ea7a05e5e63f49dd9b6864fa602dc684,
title = "Cell-free DNA testing: future applications in gastroenterology and hepatology",
abstract = "The application of next-generation sequencing in clinical practice is increasing as accuracy and interpretation have improved and the cost continues to decline rapidly. Cell-free DNA is a unique source for next-generation sequencing that could change routine clinical practice in gastroenterology and hepatology. Testing of cell-free DNA in blood and fecal samples is an easy, rapid, and noninvasive method to assess for premalignant, malignant, metabolic, infectious, inflammatory, and autoimmune gastrointestinal and liver diseases. In this review, we describe cell-free DNA technologies, current applications of cell-free DNA testing, and proposed cell-free DNA targets for gastrointestinal and hepatic diseases, with a specific focus on malignancy. In addition, we provide commentary on how cell-free DNA can be integrated into clinical practice and help guide diagnosis, prognosis, disease management, and therapeutic response.",
keywords = "cell-free DNA, gastroenterology and hepatology, individualized medicine",
author = "Inuk Zandvakili and Lazaridis, {Konstantinos N}",
year = "2019",
month = "4",
day = "1",
doi = "10.1177/1756284819841896",
language = "English (US)",
volume = "12",
journal = "Therapeutic Advances in Gastroenterology",
issn = "1756-283X",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Cell-free DNA testing

T2 - future applications in gastroenterology and hepatology

AU - Zandvakili, Inuk

AU - Lazaridis, Konstantinos N

PY - 2019/4/1

Y1 - 2019/4/1

N2 - The application of next-generation sequencing in clinical practice is increasing as accuracy and interpretation have improved and the cost continues to decline rapidly. Cell-free DNA is a unique source for next-generation sequencing that could change routine clinical practice in gastroenterology and hepatology. Testing of cell-free DNA in blood and fecal samples is an easy, rapid, and noninvasive method to assess for premalignant, malignant, metabolic, infectious, inflammatory, and autoimmune gastrointestinal and liver diseases. In this review, we describe cell-free DNA technologies, current applications of cell-free DNA testing, and proposed cell-free DNA targets for gastrointestinal and hepatic diseases, with a specific focus on malignancy. In addition, we provide commentary on how cell-free DNA can be integrated into clinical practice and help guide diagnosis, prognosis, disease management, and therapeutic response.

AB - The application of next-generation sequencing in clinical practice is increasing as accuracy and interpretation have improved and the cost continues to decline rapidly. Cell-free DNA is a unique source for next-generation sequencing that could change routine clinical practice in gastroenterology and hepatology. Testing of cell-free DNA in blood and fecal samples is an easy, rapid, and noninvasive method to assess for premalignant, malignant, metabolic, infectious, inflammatory, and autoimmune gastrointestinal and liver diseases. In this review, we describe cell-free DNA technologies, current applications of cell-free DNA testing, and proposed cell-free DNA targets for gastrointestinal and hepatic diseases, with a specific focus on malignancy. In addition, we provide commentary on how cell-free DNA can be integrated into clinical practice and help guide diagnosis, prognosis, disease management, and therapeutic response.

KW - cell-free DNA

KW - gastroenterology and hepatology

KW - individualized medicine

UR - http://www.scopus.com/inward/record.url?scp=85064565131&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064565131&partnerID=8YFLogxK

U2 - 10.1177/1756284819841896

DO - 10.1177/1756284819841896

M3 - Review article

VL - 12

JO - Therapeutic Advances in Gastroenterology

JF - Therapeutic Advances in Gastroenterology

SN - 1756-283X

ER -